Conditions: Ulcerative Colitis
Keywords: ulcerative colitis compliance mesalamine clinical study clinical trial clinical research maintenance long term uc study uc trial uc research open label once a day once daily daily dosing simple oral
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 290
Healthy volunteers: no

Brief summary:
To evaluate the percentage of subjects with clinical recurrence of UC at 6 months using MMX mesalamine once daily.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: MMX Mesalamine
Intervention descriptions: intervention 1: MMX™ mesalamine 2.4g/day to 4.8g/day once-daily (QD) (two to four 1.2g tablets MMX™ mesalamine, dosed QD,respectively).

Protocol document: